MODRNA

Welcome to the Brand page for “MODRNA”, which is offered here for Medical, biological, cosmeceutical and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, preparations for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; rna-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents;biochemicals, proteins and polypeptides for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, and for use in the manufacture of cosmetics and food or nutritional supplement; biochemicals, proteins and polypeptides for use in the manufacture of pharmaceuticals for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use;custom design and development of medical, biological, cosmeceutical and pharmaceutical preparations for others; design, development, and testing of new products for others in the fields of rna-based therapeutics, therapeutic agents, and medical diagnostic reagents; consultation and research for others in the field of rna-based therapeutics, therapeutic agents, and medical diagnostic reagents;.

Its status is currently believed to be active. Its class is unavailable. “MODRNA” is believed to be currently owned by “Moderna Therapeutics, Inc.”